26114310|t|Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
26114310|a|The acetylcholinesterase inhibitory and/or antitumour activities of amino-, thio- and ester-derivatives of avarol selected were evaluated for the first time at in vitro conditions. Avarol-3',4'-dithioglycol (1) and avarol-4'-(3)mercaptopropionic acid (3) were shown to be the best inhibitors of the enzyme tested (0.50 microg and IC50 0.05 mM and 0.50 microg and IC50 0.12 mM, respectively), while 4'-tryptamine-avarone (9) and avarol-3'-(3)mercaptopropionic acid (2) exhibited the highest cytotoxicity against the human breast T-47D cancer cell line (IC50 0.66 microg/mL and 1.25 microg/mL, respectively). According to experimental data obtained, the sesquiterpenoid hydroquinone structure of bioactive avarol derivatives may inspire development of new pharmacologically useful substances to be used in the treatment of Alzheimer's disease and/or human breast tumour. 
26114310	59	74	thio- and ester	Chemical	-
26114310	90	96	avarol	Chemical	MESH:C023663
26114310	102	122	acetylcholinesterase	Gene	43
26114310	174	189	thio- and ester	Chemical	-
26114310	205	211	avarol	Chemical	MESH:C023663
26114310	279	304	Avarol-3',4'-dithioglycol	Chemical	-
26114310	313	348	avarol-4'-(3)mercaptopropionic acid	Chemical	-
26114310	496	517	4'-tryptamine-avarone	Chemical	-
26114310	526	561	avarol-3'-(3)mercaptopropionic acid	Chemical	-
26114310	613	618	human	Species	9606
26114310	619	638	breast T-47D cancer	Disease	MESH:D001943
26114310	750	778	sesquiterpenoid hydroquinone	Chemical	-
26114310	802	808	avarol	Chemical	MESH:C023663
26114310	919	938	Alzheimer's disease	Disease	MESH:D000544
26114310	946	951	human	Species	9606
26114310	952	965	breast tumour	Disease	MESH:D001943
26114310	Negative_Correlation	MESH:C023663	MESH:D000544
26114310	Negative_Correlation	MESH:C023663	MESH:D001943
26114310	Negative_Correlation	MESH:C023663	43

